文献速递肾癌与肾肿瘤

医院病例量对根治性肾切除加下腔静脉癌栓取出术结局的影响

Impact of Hospital Case Volume on Outcomes Following Radical Nephrectomy and Inferior Vena Cava Thrombectomy.
PubMed 文献 · Eur Urol Oncol · 2018-11-16

基于美国国家癌症数据库分析2664例pT3b-c肾细胞癌行RN-IVCT患者,发现高病例量医院(年手术量>3例)患者中位总生存为60个月,显著优于中、低量医院(53和42个月,P=0.009),且多变量校正后高量医院全因死亡风险较低量医院降低24%(HR 0.76, 95%CI 0.65-0.89, P=0.001),短期死亡率无显著差异。

要点

  • 高病例量医院(年RN-IVCT>3例)患者中位OS达60个月,低量医院为42个月。
  • 多变量校正后高量医院较低量医院全因死亡风险降低24%(HR 0.76, 95%CI 0.65-0.89)。
  • 医院病例量与30天和90天短期死亡率无显著差异。

核心结论

  • 高医院病例量与RN-IVCT患者更长的总生存相关,支持对晚期肾细胞癌实施集中化诊疗。

研究设计与样本

  • 回顾性队列研究,查询美国国家癌症数据库,纳入2664例接受RN-IVCT的pT3b-c肾细胞癌患者,覆盖573家医院。
  • 医院按病例量百分位分为低量(<75百分位,年<0.67例)、中量(75-95百分位,年0.67-2.99例)、高量(>95百分位,年>3例),分别对应435、108、30家医院,覆盖28.5%、34.5%、37%的病例。

主要发现

  • 低、中、高量医院患者的中位总生存分别为42、53、60个月(P=0.009)。
  • 多变量校正后,高量医院较低量医院全因死亡风险降低24%(HR 0.76, 95%CI 0.65-0.89; P=0.001)。
  • 按医院病例量分层,30天和90天短期死亡率无显著差异。

临床怎么用

  • 对于接受RN-IVCT的晚期肾细胞癌患者,可优先考虑转诊至高病例量中心以改善长期生存。
  • 临床决策中可将医院年RN-IVCT病例量(>3例/年)作为选择治疗机构的参考指标。

局限性

  • 研究为回顾性数据库分析,可能存在选择偏倚和未测量混杂因素。
  • 高病例量医院的定义基于病例量百分位,年手术量阈值较低(>3例/年)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radical nephrectomy with inferior vena cava thrombectomy (RN-IVCT) is a complicated procedure for which the impact of hospital case volume on overall survival (OS) is unknown. OBJECTIVE: To assess the degree to which renal cell carcinoma (RCC) with inferior vena cava tumor thrombus (IVC-TT) care is centralized and to evaluate the impact of hospital case volume on outcomes following RN-IVCT. DESIGN, SETTING, AND PARTICIPANTS: The National Cancer Data Base was queried for patients with pT3b-c RCC treated with RN-IVCT. Hospitals were classified by case volume percentile as low (<75th percentile, <0.67 cases annually), intermediate (75th-95th percentile, 0.67-2.99 cases annually), or high (>95th percentile, >3 cases annually). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was OS. Secondary outcomes were short-term (30- and 90-d) mortality rates according to hospital case volume. Kaplan-Meier curves and Cox regression model were used to evaluate OS and the effect of covariables. RESULTS AND LIMITATIONS: There were 2664 cases of RN-IVCT for pT3b-c tumors reported by 573 institutions, of which 435, 108, and 30 were classified as low, intermediate, and high volume, accounting for 28.5%, 34.5%, and 37% of cases, respectively. Treatment at high-volume institutions was associated with better OS: the median OS was 42, 53, and 60 months for low, intermediate and high-volume centers, respectively (p=0.009). After multivariable adjustment, treatment at a high-volume institution was associated with a 24% relative risk reduction for all-cause mortality compared to treatment at a low-volume institution (hazard ratio 0.76, 95% confidence interval 0.65-0.89; p=0.001). There was no significant difference in short-term mortality following RN-IVCT when stratified by hospital case volume. CONCLUSIONS: Higher hospital case volume was associated with longer OS for patients undergoing RN-IVCT. These findings support efforts to centralize care for cases of advanced RCC. PATIENT SUMMARY: In this study we looked at the impact of hospital case volume on survival following surgery for renal cell carcinoma and inferior vena cava thrombectomy. Survival was significantly better in high-volume hospitals performing three or more procedures per year.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Freifeld Y, Woldu SL, Singla N, et al. Impact of Hospital Case Volume on Outcomes Following Radical Nephrectomy and Inferior Vena Cava Thrombectomy. Eur Urol Oncol. 2018. PMID: 31411983. doi:10.1016/j.euo.2018.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。